Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?

被引:0
|
作者
Michael D. Puchalski
Richard V. Williams
Bojana Askovich
C. Todd Sower
Kan H. Hor
Jason T. Su
Nathan Pack
Edward Dibella
William M. Gottliebson
机构
[1] University of Utah and Primary Children’s Medical Center,Department of Pediatrics
[2] Cincinnati Children’s Hospital Medical Center,Department of Radiology and Bioengineering
[3] University of Utah,undefined
关键词
Duchenne muscular dystrophy; Magnetic resonance imaging; Cardiomyopathy;
D O I
暂无
中图分类号
学科分类号
摘要
Background Progressive cardiomyopathy is a common cause of death in Duchenne muscular dystrophy (DMD), presumably secondary to fibrosis of the myocardium. The posterobasal and left lateral free wall of the left ventricle (LV) are initial sites of myocardial fibrosis pathologically. The purposes of this study were to assess whether cardiac magnetic resonance imaging (CMRI), utilizing late gadolinium enhancement (LGE), could identify fibrosis in selective areas of the myocardium, and to assess the relationship of the presence and extent of fibrosis to LV function. Methods The cardiology databases at Primary Children’s Medical Center and Cincinnati Children’s Hospital Medical Center were reviewed to identify patients with DMD who had undergone a CMRI within the last 2 years. Age, LV ejection fraction, LV mass, presence and location of LGE were documented. Volumes were measured using MASS (Medis, Inc.) to calculate ejection fraction and mass. LGE images were acquired and when positive, customized computer assisted sizing of the areas of late gadolinium enhancement were performed on all slices. Normal function was defined as LV ejection fraction >54%. Results A total of 74 patients with DMD had complete data sets (median age 13.7 years, range 7.7–26.4). Twenty-four patients (32%) had LGE involving the posterobasal region of the LV in a sub-epicardial distribution. Those patients with more involvement had spread to the inferior and left lateral free wall with progressive transmural fibrous replacement. There was relative sparing of the interventricular septum and right ventricle. Patients with LGE were significantly older than those without (mean age 16.4 vs 12.9 years, P < 0.001). LGE was positively associated with BSA-adjusted LV mass, LV end-diastolic volume, LV end-systolic volume, and RV end-systolic volume but inversely correlated with ejection fraction of the LV (P < 0.001) and RV (P = 0.004). Conclusions LGE by CMRI is able to detect fibrosis in selective regions of myocardium in patients with DMD. Unfavorable LV remodeling, with a corresponding decreased ejection fraction, is associated with the presence of LGE. Serial studies are warranted to determine if LGE precedes a decrease in function, and if early medical management is useful in preventing progression once LGE is documented.
引用
收藏
页码:57 / 63
页数:6
相关论文
共 50 条
  • [21] Cardiomyopathy in a carrier of Duchenne's muscular dystrophy
    Davies, JE
    Winokur, TS
    Aaron, MF
    Benza, RL
    Foley, BA
    Holman, WL
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (07): : 781 - 784
  • [22] Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics
    Abdallah Fayssoil
    Olivier Nardi
    David Orlikowski
    Djillali Annane
    [J]. Heart Failure Reviews, 2010, 15 : 103 - 107
  • [23] Decoding Dysfunction in Duchenne Muscular Dystrophy Cardiomyopathy
    Reza, Nosheen
    Owens, Anjali T.
    [J]. CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (01): : E002051
  • [24] SPIRONOLACTONE THERAPY FOR CARDIOMYOPATHY IN DUCHENNE MUSCULAR DYSTROPHY
    Ploutz, Michelle
    Moore, Ryan
    Ashiki, Masatoshi
    Wisotzkey, Bethany
    Taylor, BreAnn
    Spurney, Christopher
    Taylor, Michael
    Jefferies, John
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 870 - 870
  • [25] Duchenne muscular dystrophy; a cardiomyopathy that can be prevented?
    Barbara J. M. Mulder
    Ernst E. van der Wall
    [J]. The International Journal of Cardiovascular Imaging, 2009, 25
  • [26] Hypertrophic cardiomyopathy in a patient with Duchenne muscular dystrophy
    Cripe, L.
    Hor, K.
    Taylor, M.
    Goldberg, P.
    Garrison, A.
    Spicer, R.
    Kinnett, K.
    Markham, L.
    Ware, S.
    [J]. NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 754 - 754
  • [27] Early-Onset Late Gadolinium Enhancement is a Prognostic Factor for Duchenne Cardiomyopathy
    Lorraine James
    Jondavid Menteer
    Lilith C. Moss
    Ramon Durazo-Arvizu
    John C. Wood
    Leigh Ramos-Platt
    Emmanuelle Tiongson
    Jennifer A. Su
    [J]. Pediatric Cardiology, 2023, 44 : 433 - 440
  • [28] Early-Onset Late Gadolinium Enhancement is a Prognostic Factor for Duchenne Cardiomyopathy
    James, Lorraine
    Menteer, Jondavid
    Moss, Lilith C.
    Durazo-Arvizu, Ramon
    Wood, John C.
    Ramos-Platt, Leigh
    Tiongson, Emmanuelle
    Su, Jennifer A.
    [J]. PEDIATRIC CARDIOLOGY, 2023, 44 (02) : 433 - 440
  • [29] Exuberant late gadolinium enhancement in hypertrophic cardiomyopathy as a precursor to 'burn out'
    Gweun, John
    Thomas, Sarah C.
    Geske, Jeffrey B.
    [J]. EUROPEAN HEART JOURNAL-CASE REPORTS, 2022, 6 (06)
  • [30] Late gadolinium enhancement in cardiomyopathy
    Alpendurada, F.
    Pennell, D. J.
    [J]. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2008, 24 (06): : 613 - 615